Abstract:Common variable immunodeficiency (CVID) is a heterogeneous primary immunodeficiency (PID) characterized by an impaired immunoglobulin production, in association with an increased susceptibility to infections and a diversity of clinical manifestations. This narrative review summarizes immunophenotypic abnormalities in CVID patients and their relevance for diagnosis and disease classification. A comprehensive search across four databases - PubMED, Web of Science, EMBASE and Google Scholar – yielded 170 relevant studies published between 1988 and April 31, 2023. Over the past decades, the role of immunophenotyping in CVID diagnosis has become evident by identifying "hallmark" immunophenotypic aberrancies in patient subsets, with some now integrated in the consensus diagnostic criteria. Furthermore, the role of immunophenotyping in subclassifying CVID in relation to clinical presentation and prognosis has been extensively studied. Certain immunophenotypic patterns consistently correlate with clinical manifestations and/or subsets of CVID, particularly those associated with noninfectious complications (i.e. low switched memory B cells, shifts in follicular helper T cell subsets, low naïve CD4 + T cells, low regulatory T cells, and expansion of CD21low B cells, often associated with autoimmunity and/or splenomegaly). Also, efforts to associate subset levels of innate immune cells, such as Natural Killer (NK) cells, invariant (i)NKT cells, innate lymphoid cells (ILCs), and dendritic cells (DCs) to CVID complications are evident albeit in a lesser degree. However, inconsistencies regarding the role of flow cytometry in classification and prognosis persist, reflecting the disease complexity, but probably also cohort variations and methodological differences between published studies. This underscores the need for collaborative efforts to integrate emerging concepts, such as standardized flow cytometry and computational tools, for a more precise CVID classification approach. Additionally, recent studies suggest a potential value of (epi)genetic-based molecular assays to this effort.

New Facets of Antibody Deficiencies

Molecular and cellular mechanisms underlying defective antibody responses

Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency

Mitigating Range Ambiguity in High PRF Radar using Inter-Pulse Binary Coding

Clinical and experimental treatment of primary humoral immunodeficiencies

Autoimmunity as a continuum in primary immunodeficiency

Primary antibody deficiencies

The role of immunophenotyping in common variable immunodeficiency: a narrative review

Autoantibodies in immunodeficiency syndromes: The Janus faces of immune dysregulation

Human primary immunodeficiency diseases: a perspective

Immunogenetic Landscape in Pediatric Common Variable Immunodeficiency

RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches

Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the <i>PIK3CD</i> Gene

B-cell biology and development

Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the PIK3CD Gene

Effect of transitory protein supplements on early fetal development in rats.

The broad spectrum of lung diseases in primary antibody deficiencies

The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management

Major histocompatibility complex class II antigen expression in nerves in leprosy; an immunoelectronmicroscopical study.

Genomics of Immune Diseases and New Therapies.